palivizumab

Modify Date: 2025-08-25 18:32:16

palivizumab Structure
palivizumab structure
Common Name palivizumab
CAS Number 188039-54-5 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of palivizumab


Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection[1].

 Names

Name palivizumab
Synonym More Synonyms

 palivizumab Biological Activity

Description Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection[1].
Related Catalog
References

[1]. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531-7.

 Chemical & Physical Properties

No Any Chemical & Physical Properties

 Synonyms

PALIVIZUMAB
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.